Biochemical Mechanisms in Chemical-Induced Lung Injury: Roles of Metabolic Activation

References

• Miller E. C., Miller J. A. Mechanisms of chemical carcinogenesis: nature of proximate carcinogens and interactions with macromolecules. Pharmacol. Rev. 1966; 18: 805
   PubMed Web of Science ®Google Scholar
• Miller J. A. Carcinogenesis by chemicals: an overview — G. H. A. Clowes Memorial Lecture. Cancer Res. 1970; 30: 559
   PubMed Web of Science ®Google Scholar
• Miller E. C. Some current perspectives on chemical carcinogenesis in humans and experimental animals: presidential address. Cancer Res. 1978; 38: 1479
   PubMed Web of Science ®Google Scholar
• Magee P. N. Activation and inactivation of chemical carcinogens and mutagens in the mammal. Essays Biochem. 1974; 10: 105
   PubMedGoogle Scholar
• Rechnagel R. O., Glende E. A. Carbon tetrachloride hepatotoxicity: an example of lethal cleavage. CRC Crit. Rev. Toxicol. 1973; 2: 263
   PubMedGoogle Scholar
• Gillette J. R., Mitchell J. R., Brodie B. B. Biochemical mechanisms of drug toxicity. Annu. Rev. Pharmacol 1974; 14: 271
   Google Scholar
• Gilette J. R. A perspective on the role of chemically reactive metabolites of foreign compounds in toxicity. 1. Correlation of changes in covalent binding of reactive metabolites with changes in the incidence and severity of toxicity. Biochem. Pharmacol. 1974; 23: 2785
   PubMed Web of Science ®Google Scholar
• Gillette J. R. A perspective on the role of chemically reactive metabolites of foreign compounds in toxicity. II. Alterations in the kinetics of covalent binding. Biochem. Pharmacol. 1974; 23: 2927
   PubMed Web of Science ®Google Scholar
• Nelson S. D., Boyd M. R., Mitchell J. R. Role of metabolic activation in chemical-induced tissue injury. Drug Metabolism Concepts, D. M. Jerina. American Chemical Society, Washington, DC 1977, chap. 8
   Google Scholar
• Boyd M. R. Role of metabolic activation in the pathogenesis of chemically induced pulmonary disease: mechanism of action of the lung-toxic furan, 4-ipomeanol. Environ. Health Perspect. 1976; 16: 127
   PubMed Web of Science ®Google Scholar
• Weisburger J. H., Weisburger E. K. Biochemical formation and pharmacological, toxicological and pathological properties of hydroxylamines and hydroxamic acids. Pharmacol. Rev. 1973; 25: 1
   PubMed Web of Science ®Google Scholar
• Judah J. D., McLean A. E., McLean E. K. Biochemical mechanism of liver injury. Am. J. Med. 1970; 49: 609
   PubMed Web of Science ®Google Scholar
• Bonse G., Henschler D. Chemical reactivity, biotransformation, and toxicity of polychlorinated aliphatic compounds. CRC Crit. Rev. Toxicol. 1976; 4: 395
   PubMed Web of Science ®Google Scholar
• Boyd M. R. Biochemical mechanisms in pulmonary toxicity of furan derivatives. Reviews in Biochemical Toxicology, E. Hodgson, J. Bend, R. Philipot. Elsevier/North Holland, New York 1980; 141
   Google Scholar
• Boyd M. R., Dutcher J. S., Buckpitt A. R. Jones, R. B., and Statham, C. N., Role of metabolic activation in extrahepatic target organ alklyation and cytotoxicity by 4-ipomeanol, a furan derivative from moldy sweet potatoes; possible implications for carcinogenesis. Naturally-Occurring Carcinogens — Mutagens and Modulators of Carcinogenesis, E. Miller, J. Miller, I. Hirono, T. Sugimura, S. Takayama. University Park Press, Baltimore 1979; 35
   Google Scholar
• Boyd M. R., Buckpitt A. R., Jones R. B., Statham C. N., Longo N. S. Metabolic activation of toxins in extrahepatic target organs and target cells. The Scientific Basis of Toxicity Assessment, H. R. Witschi. Elsevier/North Holland, New York 1980; 141
   Google Scholar
• Boyd M. R. Effects of inducers and inhibitors on drug-metabolizing enzymes and drug toxicity in extrahepatic tissues. Environmental Chemicals, Enzyme Function and Human Disease. Excerpta Medica, Amsterdam, Ciba Foundation Symposium No. 76, in press
   Google Scholar
• Witschi H., Côté M. G. Primary pulmonary responses to toxic agents. CRC Crit. Rev. Toxicol. 1977; 5: 23
   PubMed Web of Science ®Google Scholar
• Hook G. E. R., Bend J. R. Pulmonary metabolism of xenobiotics. Life Sci. 1976; 18: 279
   PubMed Web of Science ®Google Scholar
• Gram T. E. Comparative aspects of mixed function oxidation by lung and liver of rabbits. Drug Metab. Rev. 1973; 2: 1
   PubMed Web of Science ®Google Scholar
• Remmer H. Pulmonary drug-metabolizing enzymes. Lung Metabolism, A. F. Junod, R. De-Haller. Academic Press, New York 1975; 133
   Google Scholar
• Junod A. F. Uptake, release, and metabolism of drugs in the lungs. Pharmac. Ther. B 1976; 2: 511
   PubMedGoogle Scholar
• Junod A. F. Mechanisms of drug accumulation in the lung. Lung Metabolism, A. F. Junod, R. DeHaller. Academic Press, New York 1975; 219
   Google Scholar
• Philpot R. M., Anderson M. W., Eling T. M. Uptake, accumulation, and metabolism of chemicals by the lung. Metabolic Functions of the Lung, Y. S. Bakhle, J. R. Vane. Marcel Dekker, New York 1977, chap. 5
   Google Scholar
• Brown E. A. B. The localization, metabolism, and effects of drugs and toxicants in lung. Drug Metab. Rev. 1974; 3: 33
   PubMed Web of Science ®Google Scholar
• Alabaster V. A. Inactivation of endogenous amines in the lungs. Metabolic Functions of the Lung, Y. S. Bakhle, J. R. Vane. Marcel Dekker, New York 1977, chap. 1
   Google Scholar
• Wilson B. J., Yang D. T. C., Boyd M. R. Toxicity of mold-damaged sweet potatoes (Ipomoea batatas). Nature (London) 1970; 227: 521
   PubMed Web of Science ®Google Scholar
• Wilson B. J., Boyd M. R., Harris T. M., Yang D. T. C. Lung edema factor from moldy sweet potatoes (. Ipomoea batatas), Nature (London) 1971; 231: 52
   PubMed Web of Science ®Google Scholar
• Boyd M. R., Harris T. M., Wilson B. J. Confirmation by chemical synthesis of the structure of 4-ipomeanol, a lung-toxic metabolite of the sweet potato (. Ipomea batatas). Nature (London) New Biol. 1972; 236: 158
   PubMed Web of Science ®Google Scholar
• Boyd M. R., Wilson B. J. Isolation and characterization of 4-ipomeanol, a lung-toxic furano-terpenoid produced by sweet potatoes. J. Agric. Food Chem. 1972; 20: 428
   PubMed Web of Science ®Google Scholar
• Wilson B. J., Boyd M. R. Sweet potato toxins stimulated byFusarium solani and Ceratocystis fimbriata. Mycotoxins, I. F. H. Purchase. Elsevier, New York 1974, chap. 15
   Google Scholar
• Boyd M. R., Burka L. T., Harris T. M., Wilson B. J. Lung-toxic furanoterpenoids produced by sweet potatoes (Ipomoea batatas) following microbial infection. Biochim. Biophys. Acta 1974; 337: 184
   PubMed Web of Science ®Google Scholar
• Peckham J. C., Mitchell F. E., Jones O. H., Jr., Doupnik B. Atypical interstitial pneumonia in cattle fed moldy sweet potatoes. J. Am. Vet. Med. Assoc. 1972; 160: 169
   PubMed Web of Science ®Google Scholar
• Doster A. R., Mitchell F. E., Farrell R. L., Wilson B. J. Effects of 4-ipomeanol, a product from mold-damaged sweet potatoes, on the bovine lung. Vet. Pathol. 1978; 15: 367
   PubMed Web of Science ®Google Scholar
• Boyd M. R., Wilson B. J. Preparative and analytical gas chromatography of ipomeamarone, a toxic metabolite of sweet potatoes (. Ipomea batatas), J. Agric. Food Chem. 1971; 19: 547
   Web of Science ®Google Scholar
• Dutcher J. S., Boyd M. R. Species and strain differences in tissue alkylation and toxicity by 4-ipomeanol: predictive value of covalent binding in the study of target organ toxicity. Toxicol. Appl. Pharmacol. 1978; 45: 267
   Web of Science ®Google Scholar
• Dutcher J. S., Boyd M. R. Species and strain differences in target organ alkylation and toxicity by 4-ipomeanol; predictive value of covalent binding in studies of target organ toxicities by reactive metabolites. Biochem. Pharmacol. 1979; 28: 3367
   PubMed Web of Science ®Google Scholar
• Boyd M. R. Evidence for the Clara cell as a site of cytochrome P450-dependent mixed-function oxidase activity in lung. Nature (London) 1977; 269: 713
   PubMed Web of Science ®Google Scholar
• Boyd M. R., Burka L. T., Neal R. A., Wilson B. J., Holscher M. M. Role of covalent binding in the toxic mechanism of the lung-edemagenic agent, 4-ipomeanol. Fed. Proc. 1974; 33: 234
   Google Scholar
• Boyd M. R., Burka L. T. In vivo studies on the relationship between target organ alkylation and the pulmonary toxicity of a chemically reactive metabolite of 4-ipomeanol. J. Pharmacol. Exp. Ther. 1978; 207: 687
   PubMed Web of Science ®Google Scholar
• Boyd M. R., Dutcher J. S. Role of renal metabolism in the pathogenesis of renal cortical necrosis by 4-ipomeanol in the mouse. Toxicol. Appl. Pharmacol. 1978; 45: 229
   Web of Science ®Google Scholar
• Jones R., Allegra C, Boyd M. Predictive value of covalent binding in target organ toxicity: age-related differences in target organ alkylation and toxicity by 4-ipomeanol. Toxicol. Appl. Pharmacol. 1979; 48: A129
   Web of Science ®Google Scholar
• Longo N. S., Boyd M. R. Sex differences in renal alkylation and toxicity by 4-ipomeanol in the mouse. Toxicol. Appl. Pharmacol., in press
   Google Scholar
• Buckpitt A. R., Boyd M. R. Xenobiotic metabolism in birds, species lacking pulmonary Clara cells. Pharmacologist 1978; 20: 181
   Google Scholar
• Fedde M. R. Respiration. Avian Physiology, P. D. Sturkie. Springer-Verlag, New York 1976, chap. 6
   Google Scholar
• Boyd M. R., Buckpitt A. R. unpublished results
   Google Scholar
• Boyd M. R., Burka L. T., Wilson B. J., Sastry B. V. R. Distribution and excretion of radioactivity in the rat after administratin of the lung-edemagenic toxin, 4-ipomeanol-14C. Toxicol. Appl. Pharmacol. 1974; 29: 132
   Web of Science ®Google Scholar
• Boyd M. R., Burka L. T., Wilson B. J. Distribution, excretion and binding of radioactivity in the rat after intraperitoneal administration of the lung-toxic furan, 4-ipomeanol-14C. Toxicol. Appl. Pharmacol. 1975; 32: 147
   PubMed Web of Science ®Google Scholar
• Staub N. C. Pulmonary edema. Physiol. Rev. 1974; 54: 678
   PubMed Web of Science ®Google Scholar
• Boyd M. R., Burka L. T., Wilson B. J., Sasame H. A. In vitro studies on the metabolic activation of the pulmonary toxin, 4-ipomeanol, by rat lung and liver microsomes. J. Pharmacol. Exp. Ther. 1978; 207: 677
   PubMed Web of Science ®Google Scholar
• Sasame H. A., Boyd M. R. Possible role of cytochrome bs as a rate-limiting factor in metabolic activation of 4-ipomeanol by lung microsomes. Fed. Proc. 1978; 37: 464
   Google Scholar
• Sasame H. A., Gillette J. R., Boyd M. R. Effects of anti-NADPH-cytochromec reductase and anti-cytochrome bs antibodies on the hepatic and pulmonary microsomal metabolism and covalent binding of the pulmonary toxin, 4-ipomeanol. Biochem. Biophys. Res. Commun. 1978; 84: 389
   PubMed Web of Science ®Google Scholar
• Sasame H. A., Boyd M. R. Paradoxical effects of cobaltous chloride and salts of other divalent metals on tissue levels of reduced glutathione and microsomal mixed-function oxidase components. J. Pharmacol. Exp. Ther. 1978; 205: 718
   PubMed Web of Science ®Google Scholar
• Guengerich F. P. Separation and purification of multiple forms of cytochrome P-450. Activities of different forms of cytochrome P-450 towards several compounds of environmental interest. J. Biol. Chem. 1977; 252: 3970
   PubMed Web of Science ®Google Scholar
• Guengerich F. P. Preparation and properties of highly purified cytochrome P-450 and NADPH-cytochrome P-450 reductase from pulmonary microsomes of untreated rabbits. Mol. Pharmacol. 1977; 13: 911
   PubMed Web of Science ®Google Scholar
• Schenkman J. B., Jansson I., Robie-Suh K. M. The many roles of cytochrome bs in hepatic microsomes. Life Sci. 1976; 19: 611
   PubMed Web of Science ®Google Scholar
• Sasame H. A., Thorgiersson S. S., Mitchell J. R., Gillette J. R. The possible involvement of cytochrome bs in the oxidation of lauric acid by microsomes from kidney cortex and liver of rats. Life Sci. 1974; 14: 35
   PubMed Web of Science ®Google Scholar
• Gillette J. R., Davis D. C., Sasame H. A. Cytochrome P-450 and its role in drug metabolism. Annu. Rev. Pharmacol. 1972; 12: 57
   PubMedGoogle Scholar
• Boyd M. R. Hepatotoxicity produced by the lung-toxic furanoterpenoid, 4-ipomeanol, after mixed-function oxidase induction: reversal of target organ for toxicity and covalent binding in rats pre-treated with 3-methyl-cholanthrene. Toxicol. Appl. Pharmacol. 1975; 33: 132
   Web of Science ®Google Scholar
• Boyd M., Statham C., Stiko A., Mitchell J., Jones R. Possible protective role of glutathione in pulmonary toxicity by 4-ipomeanol. Toxicol. Appl. Pharmacol. 1979; 48: A66
   Web of Science ®Google Scholar
• Buckpitt A. R., Boyd M. R. Determination of electrophilic metabolites produced during microsomal metabolism of 4-ipomeanol by high-pressure anion exchange chromatography of the glutathione adducts. Fed. Proc. 1979; 38: 692
   Google Scholar
• Statham C. N., Boyd M. R. Distribution and metabolism of the pulmonary toxin 4-ipomeanol, in control and diethyl maleate-treated rats. Pharmacologist 1979; 21: 195
   Google Scholar
• Nelson S. D., Buckpitt A. R., Boyd M. R. Unpublished results
   Google Scholar
• Mitchell J. R., Jollow D. J., Potter W. Z., Gillette J. R., Brodie B. B. Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. J. Pharmacol. Exp. Ther. 1973; 187: 211
   PubMed Web of Science ®Google Scholar
• Jollow D. J., Mitchell J. R., Zampaglione N., Gillette J. R. Bromobenzene induced liver necrosis. Protective role of glutathione and evidence for 3, 4-bromobenzene oxide as the hepatotoxic intermediate. Pharmacology 1974; 11: 151
   PubMed Web of Science ®Google Scholar
• Mitchell J. R., Boyd M. R. Dose thresholds, host susceptibility, and Pharmacokinetic considerations in the evaluation of toxicity from chemically reactive metabolites. Proc. 1st Int. Congr. Toxicology, G. L. Plaa, W. A. M. Duncan. Academic Press, New York 1978; 169
   Google Scholar
• Boyd M. R., Wilson B. J., Sastry B. V. R. Acute toxicity and development of tolerance to 4-ipomeanol, a lung edemagenic toxin from sweet potatoes (Ipomoea batatas). 5th Int. Congr. Pharmacol., San Francisco, July 23 to 28, 1972, 28
   Google Scholar
• Boyd M. R., Burka L. T., Osborne B. A., Wilson B. J. Studies on the mechanism of tolerance development to the pulmonary toxicity of 4-ipomeanol. Toxicol. Appl. Pharmacol. 1975; 33: 135
   Web of Science ®Google Scholar
• Fairchild E. J. Tolerance mechanisms. Determinants of lung responses to injurious agents. Arch. Environ. Health 1967; 14: 111
   PubMed Web of Science ®Google Scholar
• Swenson D. H., Miller E. C., Miller J. A. Aflatoxin Bl-2–3-oxide: evidence for its formation in rat liverin vivo and by human liver microsomes. in vitro, Biochem. Biophys. Res. Commun. 1974; 60: 1036
   PubMed Web of Science ®Google Scholar
• Mitchell J. R., Potter W. Z., Hinson J. A., Jollow D. J. Hepatic necrosis is caused by furosemide. Nature (London) 1974; 251: 508
   PubMed Web of Science ®Google Scholar
• Mitchell J. R., Nelson S. D., Potter W. Z., Sasame H. A., Jollow D. J. Metabolic activation of furosemide to a chemically reactive, hepatotoxic metabolite. J. Pharmacol. Exp. Ther. 1976; 41: 199
   Google Scholar
• McMurtry R. J., Mitchell J. R. Renal and hepatic necrosis after metabolic activation of 2-substituted furans and thiophenes, including furosemide and cephaloridine. Toxicol. Appl. Pharmacol. 1977; 42: 285
   PubMed Web of Science ®Google Scholar
• Wirth P. J., Bettis C. J., Nelson W. L. Microsomal metabolism of furosemide. Evidence for the nature of the reactive intermediate involved in covalent binding. Mol. Pharmacol. 1976; 12: 759
   PubMed Web of Science ®Google Scholar
• Gurtoo H. L., Bejba N. Hepatic microsomal mixed-function oxygenase: enzyme multiplicity for the metabolism of carcinogens to DNA-binding metabolites. Biochem. Biophys. Res. Commun. 1974; 61: 735
   PubMed Web of Science ®Google Scholar
• Longo N., Boyd M. In vitro metabolic activation of the pulmonary toxin 4-ipomeanol, by lung slices and isolated whole lungs. Toxicol. Appl. Pharmacol. 1979; 48: A130
   Web of Science ®Google Scholar
• Saunders R., Griffith J., Saalfeld F. Identification of some organic smog components based on rain water analysis. Biomed. Mass Spectrom. 1974; 1: 192
   PubMedGoogle Scholar
• Went F. W. Organic matter in the atmosphere, and its possible relation to petroleum formation. Proc. Natl. Acad. Sci. U.S.A. 1960; 46: 212
   PubMed Web of Science ®Google Scholar
• Rasmussen R. J. What do the hydrocarbons from trees contribute to air pollution. J. Air Pollut. Control Assoc. 1972; 22: 537
   PubMed Web of Science ®Google Scholar
• Smith G. Smog-origin-it may not be man-made. Rocky Mount. Med. J. 1967; 64: 55
   PubMedGoogle Scholar
• Mathews J. Navy scientists' study hints trees to blame for D.C. pollution. The Washington Post June 10, 1975; Cl
   Google Scholar
• Boyd M., Statham C, Franklin R., Mitchell J. Pulmonary bronchiolar alkylation and necrosis by 3-methylfuran, a naturally occurring potential atmospheric contaminant. Nature (London) 1978; 272: 270
   PubMed Web of Science ®Google Scholar
• Statham C. N., Franklin R. B., Boyd M. R. Pulmonary bronchiolar alkylation and necrosis by 3-methylfuran, a potential atmospheric contaminant derived from natural sources. Toxicol. Appl. Pharmacol. 1978; 45: 111
   Web of Science ®Google Scholar
• Statham C, Gilly P., Boyd M. unpublished results
   Google Scholar
• Seawright A. A., Mattocks A. R. The toxicity of two synthetic 3-substituted furan carbamates. Experientia 1973; 29: 1197
   PubMedGoogle Scholar
• Guengerich F. P. Studies on the activation of a model furan compound — toxicity and covalent binding of 2-(N-ethylcarbamoylhydroxymethyl) furan. Biochem. Pharmacol. 1909; 26, 1977
   Google Scholar
• Wilson B. J., Garst J. E., Linnabary R. D., Channell R. B. Perilla ketone: a potent lung toxin from the mint plant,Perilla frutescens Britton. Science 1977; 197: 573
   PubMed Web of Science ®Google Scholar
• Franklin R. B., Boyd M. R. Studies on toxic, alkylating metabolites of 2-methylfuran. Toxicol. Appl. Pharmacol. 1978; 45: 279
   Web of Science ®Google Scholar
• Recknagel R. O. Carbon tetrachloride hepatotoxicity. Pharmacol. Rev. 1967; 19: 145
   PubMed Web of Science ®Google Scholar
• Villarruel M. C., Toranzo E. G., Castro J. A. Carbon tetrachloride activation, lipid peroxi-dation, and the mixed function oxygenase activity of various rat tissues. Toxicol. Appl. Pharmacol. 1977; 41: 337
   PubMed Web of Science ®Google Scholar
• Valdivia E., Sonnad J. Fatty change of the granular pneumocyte in CCI4 intoxication. Arch. Pathol. 1966; 81: 514
   PubMedGoogle Scholar
• Gould V. E., Smuckler E. A. Alveolar injury in acute carbon tetrachloride intoxication. Arch. Intern. Med. 1971; 128: 109
   PubMed Web of Science ®Google Scholar
• Chen W. J., Chi E. Y., Smuckler E. A. Carbon tetrachloride-induced changes in mixed function oxidases and microsomal cytochromes in the rat lung. Lab. Invest. 1977; 36: 388
   PubMed Web of Science ®Google Scholar
• Longo N., Statham C, Sasame H., Boyd M. Pulmonary Clara-cell damage by carbon tetrachloride. Fed. Proc. 1978; 37: 505
   Google Scholar
• Boyd M., Statham C, Longo N. The pulmonary clara cell as a target for toxic chemicals requiring metabolic activation; studies with carbon tetrachloride. J. Pharmacol. Exp. Ther. 1980; 212: 109
   PubMed Web of Science ®Google Scholar
• Willis R. J., Recknagel R. O. Potentiation by carbon tetrachloride of NADPH-dependent lipid peroxidation in lung microsomes. Toxicol. Appl. Pharmacol. 1979; 47: 89
   PubMed Web of Science ®Google Scholar
• Brodie B. B., Reid W. D., Cho A. K., Sipes G., Krishna G., Gillette J. R. Possible mechanism of liver necrosis caused by aromatic organic compounds. Proc. Natl. Acad. Sci. U.S.A. 1971; 68: 160
   PubMed Web of Science ®Google Scholar
• Reid W. D., Illett K. F., Glick J. M., Krishna G. Metabolism and binding of aromatic hydrocarbons in the lung. Am. Rev. Respir. Dis. 1973; 107: 539
   PubMed Web of Science ®Google Scholar
• Mahvi D., Bank H., Harley R. Morphology of a naphthalene-induced bronchiolar lesion. Am. J. Pathol. 1977; 86: 559
   Web of Science ®Google Scholar
• Jerina D. M., Daly J. W. Arene oxides: a new aspect of drug metabolism. Science 1974; 185: 573
   PubMed Web of Science ®Google Scholar
• Mackenzie J. B., Mackenzie C. G. Production of pulmonary edema by thiourea in the rat and its relation to age. Proc. Soc. Exp. Biol. Med. 1943; 54: 34
   Google Scholar
• Dieke S. H., Richter C. P. Acute toxicity of thiourea to rats in relation to age, diet, strain and species variation. J. Pharmacol. Exp. Ther. 1945; 83: 195
   Web of Science ®Google Scholar
• Dieke S. H., Allen G. S., Richter C. P. The acute toxicity of thioureas and related compounds to wild and domestic Norway rats. J. Pharmacol. Exp. Ther. 1947; 90: 260
   PubMed Web of Science ®Google Scholar
• Richter C. P. The development and use of alphanaphthylthiourea (ANTU) as a rat poison. JAMA 1945; 129: 927
   PubMed Web of Science ®Google Scholar
• McClosky W. T., Smith M. I. Studies on the pharmacologic action and the pathology of alphanaphthylthiourea (ANTU). I. Pharmacology. Public Health Rep. 1945; 60: 1101
   PubMed Web of Science ®Google Scholar
• Dieke S. H., Richter C. P. Age and species variation in the acute toxicity of alphanaphthylthiourea. Proc. Soc. Exp. Biol. Med. 1946; 62: 22
   PubMed Web of Science ®Google Scholar
• Richter C. P. The physiology and cytology of pulmonary edema and pleural effusion produced in rats by alphanaphthylthiourea (ANTU). J. Thoracic Surg. 1952; 23: 66
   Google Scholar
• Bohm G. M. Vascular permeability changes during experimentally produced pulmonary edema in rats. J. Pathol. Bacteriol. 1966; 92: 151
   PubMedGoogle Scholar
• Cunningham A. L., Hurley J. V. Alphanaphthylthiourea-induced pulmonary edema in the rat: a topographical and electronmicroscope study. J. Pathol. 1972; 106: 25
   PubMed Web of Science ®Google Scholar
• Meyrick B., Miller J., Reid L. Pulmonary oedema induced by ANTU, or by high or low oxygen concentrations in rat — an electron microscope study. Br. J. Exp. Pathol. 1972; 53: 347
   PubMed Web of Science ®Google Scholar
• Saunders J. P., Spaulding R. C. Effects of some substituted thioureas on alphanaphthylthiourea (ANTU) toxicity to rats. Proc. Soc. Exp. Biol. Med. 1951; 76: 84
   PubMed Web of Science ®Google Scholar
• Byerrum R. U. Influence of dietary iodine on susceptibility of rats to alphanaphthylthiourea poisoning. Proc. Soc. Exp. Biol. Med. 1946; 62: 328
   PubMed Web of Science ®Google Scholar
• Van Den Brink H. A. S., Kelly H., Stone M. G. Innate and drug-induced resistance to acute lung damage caused in rats by α-naphthylthiourea (ANTU) and related compounds. Br. J. Exp. Pathol. 1976; 57: 621
   PubMedGoogle Scholar
• Byerrum R. U., Dubois K. P. The influence of diet on the susceptibility of rats to alphanaphthylthiourea. J. Pharmacol. Exp. Ther. 1947; 90: 321
   PubMed Web of Science ®Google Scholar
• Byerrum R. U., Cochran K. W., Dubois K. P. Influence of alphanaphthylthiourea (ANTU) on iodine metabolism. Proc. Soc. Exp. Biol. Med. 1950; 73: 661
   PubMed Web of Science ®Google Scholar
• Richter C. P. Biological factors involved in poisoning rats with alphanaphthylthiourea. Proc. Soc. Exp. Biol. Med. 1946; 63: 364
   PubMed Web of Science ®Google Scholar
• Meyer B. J., Saunder J. P. The effects of thioureas and related compounds on alphanaphthylthiourea (ANTU) toxicity to rats. J. Pharmacol. Exp. Ther. 1949; 97: 432
   PubMed Web of Science ®Google Scholar
• Sobonya R. E., Kleinerman J. Recurrent pulmonary edema induced by α-naphthylthiourea. Am. Rev. Respir. Dis. 1973; 108: 926
   PubMedGoogle Scholar
• Dubois K. P., Holm L. W., Doyle W. L. Biochemical changes following poisoning of rats by alphanaphthylthiourea. Proc. Soc. Exp. Biol. Med. 1946; 61: 102
   PubMed Web of Science ®Google Scholar
• Giri S. N., Combs A. B. Sulfur-containing compounds and tolerance in the prevention of certain metabolic effects of phenylthiourea. Toxicol. Appl. Pharmacol. 1970; 16: 709
   PubMed Web of Science ®Google Scholar
• Karel L., Meyer B. J. The effect of various sulfur-containing compounds on alphanaphthylthi-ourea (ANTU) toxicity to rats. J. Pharmacol. Exp. Ther. 1948; 93: 414
   PubMed Web of Science ®Google Scholar
• Giri S. N., Hollinger M. A., Cross C. E., Dungworth D. L. Effects of thiourea on pulmonary edema, pleural and peritoneal effusions and toxicity in rats pretreated with actinomycin. D, Toxicology 1974; 2: 211
   PubMed Web of Science ®Google Scholar
• Williams R. T. Acquisitions recentes dans l'etude du metabolism de substances toxiques. Ann. Biol. Clin. (Paris) 1965; 23: 7
   Web of Science ®Google Scholar
• Boyd M. R., Norman B. J., Neal R. A. Studies of toxicity and of development of tolerance of alphanaphthylthiourea (ANTU). Pharmacologist 1974; 16: 239
   Google Scholar
• Hollinger M. A., Giri S. N., Alley M., Budd E., Hwang F. Tissue distribution and binding of radioactivity from14C-thiourea in the rat. Drug Metab. Dispos. 1974; 2: 521
   PubMed Web of Science ®Google Scholar
• Boyd M. R., Neal R. A. Studies on the mechanism of toxicity and of development of tolerance to the pulmonary toxin, α-naphthylthiourea (ANTU). Drug. Metab. Dispos. 1976; 4: 314
   PubMed Web of Science ®Google Scholar
• Hollinger M. A., Giri S. N., Hwang F. Binding of radioactivity from14C-thiourea to rat lung protein. DrugMetab. Dispos. 1976; 4: 119
   PubMed Web of Science ®Google Scholar
• Hollinger M. A., Giri S. N., Budd E. A pharmacodynamic study of [14C]-thiourea toxicity in immature, tolerant, and nontolerant rats. Toxicol. Appl. Pharmacol. 1976; 37: 545
   PubMed Web of Science ®Google Scholar
• Dalvi R. R., Poore R. E., Neal R. A. Studies of the metabolism of carbon disulfide by rat liver microsomes. Life Sci. 1974; 14: 1785
   PubMed Web of Science ®Google Scholar
• Kamataki T., Lee Lin M. C. M., Belcher D. H., Neal R. A. Studies of the metabolism of parathion with an apparently homogenous preparation of rabbit liver cytochrome P-450. Drug Metab. Dispos. 1976; 4: 180
   PubMed Web of Science ®Google Scholar
• Hunter A. L., Neal R. A. Inhibition of hepatic mixed-function oxidase activityin vitro andin vivo by various thiono-sulfur-containing compounds. Biochem. Pharmacol. 2199; 24, 1975
   Google Scholar
• De Matteis F. Covalent binding of sulfur to microsomes and loss of cytochrome P-450 during the oxidative desulfuration of several chemicals. Mol. Pharmacol. 1974; 10: 849
   Web of Science ®Google Scholar
• De Matteis F., Seawright A. A. Oxidative metabolism of carbon disulfide by the rat. Effect of treatments which modify the liver toxicity of carbon disulfide. Chem. Biol. Interact. 1973; 7: 375
   PubMed Web of Science ®Google Scholar
• Bond E. J., De Matteis F. Biochemical changes in rat liver after administration of carbon disulfide, with particular reference to microsomal changes. Biochem. Pharmacol. 1969; 18: 2531
   PubMed Web of Science ®Google Scholar
• Poulsen L. L., Hyslop R. M., Ziegler D. M. S-oxidation of thioureylenes catalyzed by a microsomal flavoprotein mixed-function oxidase. Biochem. Pharmacol. 1974; 23: 3431
   PubMed Web of Science ®Google Scholar
• McLean E. K. The toxic actions of pyrrolizidine (Senecio) alkaloids. Pharmacol. Rev. 1970; 22: 429
   PubMedGoogle Scholar
• Mattocks A. R. Toxicity and metabolism of Senecio alkaloids. Phytochemical Ecology, J. B. Har-borne. Academic Press, New York 1972, chap. 11
   Google Scholar
• Mattocks A. R. Mechanisms of pyrrolizidine alkaloid toxicity. Proc. 5th Int. Congr. Pharmacology. S. Karger, Basel 1973; Vol. 2: 114
   Google Scholar
• Jago M. V., Edgar J. A., Smith L. W., Culvenor C. C. J. Metabolic conversion of heliotri-dine-based pyrrolizidine alkaloids to dehydroheliotridine. Mol. Pharmacol. 1970; 6: 402
   PubMed Web of Science ®Google Scholar
• Hsu I. C., Allen J. R., Chesney C. F. Identification and toxicological effects of dehydroretro-necine, a metabolite of monocrotaline. Proc. Soc. Exp. Biol. Med. 1973; 144: 834
   PubMed Web of Science ®Google Scholar
• Mattocks A. R., White I. N. H. The conversion of pyrrolizidine alkaloids to N-oxides and to dihydropyrrolizine derivatives by rat liver microsomes. in vitro, Chem. Biol. Interact. 1971; 3: 383
   PubMed Web of Science ®Google Scholar
• Allen J. R., Carstens L. A. Pulmonary vascular occulusions initiated by endothelial lysis in monocrotaline-intoxicated rats. Exp. Mol. Pathol. 1970; 13: 159
   PubMed Web of Science ®Google Scholar
• Kay J. M., Heath D., Smith P., Bras G., Summerell J. Fulvine and the pulmonary circulation. Thorax 1971; 26: 249
   PubMed Web of Science ®Google Scholar
• Chesney C. F., Allen J. R. Monocrotaline induced pulmonary vascular lesions in non-human primates. Cardiovasc. Res. 1973; 7: 508
   PubMed Web of Science ®Google Scholar
• Wagenvoort C. A., Wagenvoort N., Dijk H. J. Effect of fulvine on pulmonary arteries and veins of the rat. Thorax 1974; 29: 522
   PubMed Web of Science ®Google Scholar
• Kay J. M., Smith P., Health D., Will J. A. Effects of phenobarbitone, cinnarizine, and zoxazolamine on the development of right ventricular hypertrophy and hypertensive pulmonary vascular disease in rats treated with monocrotaline. Cardiovasc. Res. 1976; 10: 200
   PubMed Web of Science ®Google Scholar
• Culvenor C. C. J., Edgar J. A., Jago M. V., Outteridge A., Peterson J. E., Smith L. W. Hepato- and pneumotoxicity of pyrrolizidine alkaloids in relation to molecular structure. Chem. Biol. Interact 1976; 12: 299
   PubMed Web of Science ®Google Scholar
• Butler W. H., Mattocks A. R., Barnes J. M. Lesions in the liver and lungs of rats given pyrrole derivatives of pyrrolizidine alkaloids. J. Pathol. 1970; 100: 169
   PubMed Web of Science ®Google Scholar
• Butler W. H. An ultrastructural study of the pulmonary lesion induced by pyrrole derivatives of the pyrrolizidine alkaloids. J. Pathol. 1970; 102: 15
   PubMed Web of Science ®Google Scholar
• Plestina R., Stoner H. B. Pulmonary oedema in rats given monocrotaline pyrrole. J. Pathol. 1972; 106: 245
   Web of Science ®Google Scholar
• Hurley J. V., Jago M. V. Pulmonary oedema in rats given dehydromonocrotaline: a topographic and electron-microscope study. J. Pathol. 1975; 117: 23
   PubMed Web of Science ®Google Scholar
• Plestina R., Stoner H. B., Jones G., Butler W. H., Mattocks A. R. Vascular changes in the lungs of rats after intravenous injection of pyrrole carbamates. J. Pathol. 1977; 121: 9
   PubMed Web of Science ®Google Scholar
• Chesney C. F., Allen J. R., Hsu I. C. Right ventricular hypertrophy in monocrotaline treated rats. Exp. Mol. Pathol. 1974; 20: 257
   PubMed Web of Science ®Google Scholar
• Allen J. R., Chesney C. F., Frazee W. J. Modifications of pyrrolizidine alkaloid intoxication resulting from altered hepatic microsomal enzymes. Toxicol. Appl. Pharmacol. 1972; 23: 470
   PubMed Web of Science ®Google Scholar
• Chesney C. F., Hsu I. C., Allen J. R. Modifications of thein vitro metabolism of the hepa-totoxic pyrrolizidine alkaloid, monocrotaline. Res. Commun. Chem. Pathol. Pharmacol. 1974; 8: 567
   PubMedGoogle Scholar
• Huxtable R., Ciaramitaro D., Einstein D. The effect of a pyrrolizidine alkaloid, monocrotaline, and a pyrrole, dehydroretronecine, on the biochemical functions of the pulmonary endothelium. Mol. Pharmacol. 1978; 14: 1189
   PubMed Web of Science ®Google Scholar
• Smith P., Health D. Paraquat. CRC Crit. Rev. Toxicol. 1976; 4: 411
   PubMed Web of Science ®Google Scholar
• Biochemical Mechanisms of Paraquat Toxicity, A. P. Autor. Academic Press, New York 1977
   Google Scholar
• Pasi A. The Toxicology of Paraquat, Diquat, and Morphamquat. Hans Huber, Bern 1978
   Google Scholar
• Heath D., Smith P. The pathology of the lung in paraquat poisoning. Biochemical Mechanisms of Paraquat Toxicity, A. P. Autor. Academic Press, New York 1977; 39
   Google Scholar
• Conning D. M., Fletcher K., Swan A. A. B. Paraquat and realted bipyridyls. Br. Med. Bull. 1969; 25: 245
   PubMed Web of Science ®Google Scholar
• Sharp C. W., Ottolenghi A., Posner H. S. Correlation of paraquat toxocity with tissue concentrations and weight loss in the rat. Toxicol. Appl. Pharmacol. 1972; 22: 241
   PubMed Web of Science ®Google Scholar
• Litchfield M. H., Daniel J. W., Longshaw S. The tissue distribution of the bipyridylium herbicides diquat and paraquat in rats and mice. Toxicology 1973; 1: 155
   PubMedGoogle Scholar
• Murray R. E., Gibson J. E. Paraquat disposition in rats, guinea pigs and monkeys. Toxicol. Appl. Pharmacol. 1974; 27: 283
   PubMed Web of Science ®Google Scholar
• Ilett K. F., Stripp B., Menard R. H., Reid W. D., Gillette J. R. Studies on the mechanism of the lung toxicity of paraquat: comparison of tissue distribution and some biochemical parameters in rats and rabbits. Toxicol. Appl. Pharmacol. 1974; 28: 216
   PubMed Web of Science ®Google Scholar
• Bus J. S., Preache M. M., Cagen S. Z., Poseur H. S., Eliason B. C., Sharp C. W., Gibson J. E. Fetal toxicity and distribution of paraquat and diquat in mice and rats. Toxicol. Appl. Pharmacol. 1975; 33: 450
   PubMed Web of Science ®Google Scholar
• Molnar I., Hayes W. Distribution and metabolism of paraquat in the rat. Toxicol. Appl. Pharmacol. 1971; 19: 405
   Web of Science ®Google Scholar
• Rose M. A., Smith L. L. Tissue uptake of paraquat and diquat. Gen. Pharmacol. 1977; 8: 173
   PubMedGoogle Scholar
• Witschi H., Kacew S., Hirai K., Côté M. In vivo oxidation of reduced nicotinamide-adenine dinucleotide phosphate by paraquat and diquat in rat lung. Chem. Biol. Interact 1977; 19: 143
   PubMed Web of Science ®Google Scholar
• Rose M. S., Smith L. L., Wyatt I. Evidence for the energy dependent accumulation of paraquat into the lung. Nature (London) 1974; 252: 314
   PubMed Web of Science ®Google Scholar
• Rose M. S., Lock E. A., Smith L. L., Wyatt I. Paraquat accumulation. Tissue and species specificity. Biochem. Pharmacol. 1976; 25: 419
   PubMed Web of Science ®Google Scholar
• Rose M. S., Smith L. L. The relevance of paraquat accumulation by tissues. Biochemical Mechanisms of Paraquat Toxicity, A. P. Autor. Academic Press, New York 1977; 71
   Google Scholar
• Lock E. A., Smith L. L., Rose M. S. Inhibition of paraquat accumulation in rat lung slices by a component of rat plasma and a variety of drugs and endogenous amines. Biochem. Pharmacol. 1976; 25: 1769
   PubMed Web of Science ®Google Scholar
• Smith L. L., Lock E. A., Rose M. S. The relationship between 5-hydroxytryptamine and paraquat accumulation into rat lung. Biochem. Pharmacol. 1976; 25: 2485
   PubMed Web of Science ®Google Scholar
• Sykes B. I., Purchase I. F. H., Smith L. L. Pulmonary ultrastructure after oral and intravenous dosage of paraquat to rats. J. Pathol. 1977; 121: 233
   PubMed Web of Science ®Google Scholar
• Daniel J. W., Gage J. C. Absorption and excretion of diquat and paraquat in rats. Br. J. lnd. Med. 1966; 23: 133
   PubMedGoogle Scholar
• Hollinger M. A., Giri S. N. Binding of radioactivity from [14C] paraquat to rat lung protein. in vitro. Res. Commun. Chem. Pathol. Pharmacol. 1978; 19: 329
   PubMedGoogle Scholar
• Bus J. S., Cagen S. Z., Olgaard M., Gibson J. E. A mechanism of paraquat toxicity in mice and rats. Toxicol. Appl. Pharmacol. 1976; 35: 501
   PubMed Web of Science ®Google Scholar
• Gage J. C. The action of paraquat and diquat on the respiration of liver cell fractions. Biochem. J. 1968; 109: 757
   PubMed Web of Science ®Google Scholar
• Bus J. S., Aust S. D., Gibson J. E. Superoxide- and singlet oxygen-catalyzed lipid peroxidation as a possible mechanism for paraquat (methyl viologen) toxicity. Biochem. Biophys. Res. Commun. 1974; 58: 749
   PubMed Web of Science ®Google Scholar
• Bassett D. J. P., Fisher A. B. Alterations of glucose metabolism during perfusion of rat lung with paraquat. Am. J. Physiol. 1978; 234: E653
   PubMed Web of Science ®Google Scholar
• Baldwin R. C., Pasi A., MacGregor J. T., Hine C. H. The rates of radical formation from the dipyridylium herbicides paraquat, diquat, and morfamquat in homogenates of rat lung, kidney, and liver: an inhibitory effect of carbon monoxide. Toxicol. Appl. Pharmacol. 1975; 32: 298
   PubMed Web of Science ®Google Scholar
• Farrington J. A., Ebert M., Land E. J., Fletcher K. Bipyridylium quaternary salts and related compounds. V. Pulse radiolysis studies of the reaction of paraquat radical with oxygen. Implications for the mode of action of bipyridyl herbicides. Biochim. Biophys. Acta. 1973; 314: 372
   PubMed Web of Science ®Google Scholar
• Davies D. S., Davies D. L. Effect ofd-propranolol and superoxide dismutase on paraquat reduction and adrenochrome formation by rat liver microsomes. Fed. Proc. 1974; 33: 228
   Google Scholar
• Montgomery M. M. Interaction of paraquat with the pulmonary microsomal fatty acid desaturase system. Toxicol. Appl. Pharmacol. 1976; 36: 543
   PubMed Web of Science ®Google Scholar
• Mason R. P., Holtzman J. L. The role of catalytic superoxide formation in the O2 inhibition of nitroreductase. Biochem. Biophys. Res. Commun. 1975; 67: 1267
   PubMed Web of Science ®Google Scholar
• Fisher H. K., Clements J. A., Wright R. R. Enhancement of oxygen toxicity by the herbicide paraquat. Am. Rev. Respir. Dis. 1973; 107: 246
   PubMed Web of Science ®Google Scholar
• Bus J. S., Gibson J. E. Postnatal toxicity of chronically administered paraquat in mice and interactions with oxygen and bromobenzene. Toxicol. Appl. Pharmacol. 1975; 33: 461
   PubMed Web of Science ®Google Scholar
• Rhodes M. L., Zavala D. C., Brown D. Hypoxic protection in paraquat poisoning. Lab. Invest. 1976; 35: 496
   PubMed Web of Science ®Google Scholar
• Smith L. L., Rose M. S. Biochemical changes in lungs exposed to paraquat. Biochemical Mechanisms of Paraquat Toxicity, A. P. Autor. Academic Press, New York 1977; 187
   Google Scholar
• Clark J. M., Lambertson C. J. Pulmonary oxygen toxicity: a review. Pharmacol. Rev. 1971; 23: 37
   PubMed Web of Science ®Google Scholar
• Crapo J. D., Tierney D. F. Superoxide dismutase and pulmonary oxygen toxicity. Am. J. Physiol. 1974; 226: 1401
   PubMed Web of Science ®Google Scholar
• Autor A. P. Reduction of parquat toxicity by superoxide dismutase. Life Sci. 1974; 14: 1309
   PubMed Web of Science ®Google Scholar
• Pederson T. C., Aust S. D. The role of superoxide and singlet oxygen in lipid peroxidation promoted by xanthineoxidase. Biochem. Biophys. Res. Commun. 1973; 52: 1071
   PubMed Web of Science ®Google Scholar
• Bus J. S., Aust S. D., Gibson J. E. Lipid peroxidation: a possible mechanism for paraquat toxicity. Res. Commun. Chem. Pathol. Pharmacol. 1975; 11: 31
   PubMedGoogle Scholar
• Bus J. S., Aust S. D., Gibson J. E. Paraquat toxicity: proposed mechanism of action involving lipid peroxidation. Environ. Health Perspect 1976; 16: 139
   PubMed Web of Science ®Google Scholar
• Bus J. S., Aust S. D., Gibson J. E. Lipid peroxidation as a proposed mechanism for paraquat toxicity. Biochemical Mechanisms of Paraquat Toxicity, A. P. Autor. Academic Press, New York 1977; 157
   Google Scholar
• Dodge A. D., Harris N. The mode of action of paraquat and diquat. Biochem. J. 1970; 118: 43P
   PubMed Web of Science ®Google Scholar
• Dodge A. D. The mode of action of the bipyridylium herbicides, paraquat and diquat. Endeavour 1971; 30: 130
   PubMed Web of Science ®Google Scholar
• King M. M., Lai E. K., McCay P. B. Singlet oxygen production associated with enzyme-catalyzed lipid peroxidation in liver microsomes. J. Biol. Chem. 1975; 250: 6496
   PubMed Web of Science ®Google Scholar
• Svingen B. A., O'Neal F. O., Aust S. D. The role of superoxide and singlet oxygen in lipid peroxidation. Photochem. Photobiol. 1978; 28: 803
   PubMed Web of Science ®Google Scholar
• Rotruck J. T., Pope A. L., Ganther H. E., Swanson A. B., Hafeman D. G., Hoekstra W. G. Selenium: biochemical role as a component of glutathione peroxidase. Science 1973; 179: 588
   PubMed Web of Science ®Google Scholar
• Christopherson B. O. Reduction of linolenic acid hydroperoxide by a glutathione peroxidase. Biochim. Biophys. Acta 1969; 176: 463
   PubMedGoogle Scholar
• Omaye S. T., Reddy K. A., Cross C. E. Enhanced lung toxicity of paraquat in selenium-deficient rats. Toxicol. Appl. Pharmacol. 1978; 43: 237
   PubMed Web of Science ®Google Scholar
• Talcott R. E., Shu H., Wei E. T. Dissociation of microsomal oxygen reduction and lipid peroxidation with the electron acceptors, paraquat and menadione. Biochem. Pharmacol. 1979; 28: 665
   PubMed Web of Science ®Google Scholar
• Shu H., Talcott R. E., Rice S. A., Wei E. T. Lipid peroxidation and paraquat toxicity. Biochem. Pharmacol. 1979; 28: 327
   PubMed Web of Science ®Google Scholar
• Steffen C., Netter K. J. On the mechanism of paraquat action on microsomal oxygen reduction and its relation to lipid peroxidation. Toxicol. Appl. Pharmacol. 1979; 47: 593
   PubMed Web of Science ®Google Scholar
• Manktelow B. W. The loss of pulmonary surfactant in paraquat poisoning: a model for the study of the respiratory distress syndrome. Br. J. Exp. Pathol. 1967; 48: 366
   PubMed Web of Science ®Google Scholar
• Robertson B., Enhörning G., Ivemark B., Modée J. Experimental respiratory distress induced by paraquat. J. Pathol. 1971; 103: 239
   PubMed Web of Science ®Google Scholar
• Fisher H. K., Clements J. A., Wright R. R. Pulmonary effects of the herbicide paraquat studied 3 days after injection in rats. J. Appl. Physiol. 1973; 35: 268
   PubMed Web of Science ®Google Scholar
• Fisher H. K., Clements J. A., Tierney D. F., Wright R. R. Pulmonary effects of paraquat in the first day after injection. Am. J. Physiol. 1975; 228: 1217
   PubMed Web of Science ®Google Scholar
• Fletcher K., Wyatt I. The composition of lung lipids after poisoning with paraquat. Br. J. Exp. Pathol. 1970; 51: 604
   PubMed Web of Science ®Google Scholar
• Fletcher K., Wyatt I. The action of paraquat on the incorporation of palmitic acid into dipal-mitoyl lecithin in mouse lungs. Br. J. Exp. Pathol. 1972; 53: 225
   PubMedGoogle Scholar
• Davies P., Allsion A. C. The significance of the lysosomes in toxicology. CRC Crit. Rev. Toxicol. 1972; 1: 283
   Google Scholar
• Calderbank A. The bipyridylium herbicides. Adv. Pest Control Res. 1968; 8: 127
   PubMedGoogle Scholar
• Goldberg B., Stern A. The role of the superoxide anion as a toxic species in the erythrocyte. Arch. Biochem. Biophys. 1977; 178: 218
   PubMed Web of Science ®Google Scholar
• Simons R. S., Jackett P. S., Carrol M. E. W., Lowrie D. B. Superoxide independence of paraquat toxicity in. Escherichia coli, Toxicol. Appl. Pharmacol. 1976; 37: 271
   PubMed Web of Science ®Google Scholar
• Davies D. S., Simons R. S., Jackett P. S., Carrol M. E., Lowrie D. B. Superoxide independence of paraquat toxicity in. Escherichia coli, Toxicol. Appl. Pharmacol. 1976; 37: 271, personal communication
   PubMed Web of Science ®Google Scholar
• Hassan H. M., Fridovich I. Superoxide radical and the oxygen enhancement of the toxicity of paraquat in. Escherichia coli, J. Biol. Chem. 1978; 253: 8113
   Web of Science ®Google Scholar
• Goldstein B. D., Rozen M. G., Quintavalla J. C., Amoruso M. A. Decrease in mouse lung and liver glutathione peroxidase activity and potentiation of the lethal effects of ozone and paraquat by the superoxide dismutase inhibitor, diethyldithiocarbamate. Biochem. Pharmacol. 1979; 28: 27
   PubMed Web of Science ®Google Scholar
• Rose M. S., Smith L. L., Wyatt I. The relevance of pentose phosphate pathway stimulation in rat lung to the mechanism of paraquat toxicity. Biochem. Pharmacol. 1976; 25: 1763
   PubMed Web of Science ®Google Scholar
• Schmitt S. L., Van Orden L. S., Autor A. P. Effect of paraquat on alveolar macrophages and type II pneumocytes isolated from rat lungs. Fed. Proc. 1977; 36: 413
   Google Scholar
• Autor A. P., Witschi H., Kacew S., Hirai K., Cote M. in vivo oxidation of reduced nicotinamide-adenine dinucleotide phosphate by paraquat and diquat in rat lung. Chem. Biol. Interact. 1977; 19: 143, personal communication
   PubMed Web of Science ®Google Scholar
• Rosenow E. C. Drug-induced hypersensitivity disease of the lung. Immunologic and Infectious Reactions in the Lung, C. H. Kirkpatrick, Reynolds. Marcel Dekker, New York 1976; 261
   Google Scholar
• Boyd M. R., Sasame H., Mitchell J. R., Catignani G. Dose-dependent pulmonary toxicity by nitrofurantoin and modification by dietary fat, vitamin E, and oxygen. Fed. Proc. 1977; 36: 405
   Google Scholar
• Boyd M. R., Sasame H. A., Mitchell J. R., Stiko A., Catignani G. L. Acute pulmonary injury in rats by nitrofurantoin and modification by vitamin E, dietary fat, and oyxgen. Am. Rev. Respir. Dis. 1979; 120: 93
   PubMed Web of Science ®Google Scholar
• Statham C. N., Sasame H. A., Longo N. S., Boyd M. R. Unpublished results
   Google Scholar
• Peterson F. Personal communication
   Google Scholar
• Boyd M. R., Osborne B. A. Studies on microsomal nitroreductase in lung and liver which catalyzes covalent binding of14C-nitrofurantoin to pulmonary and hepatic protein. Fed. Proc. 1975; 34: 756
   Google Scholar
• Boyd M. R., Stiko A., Sasame H. A. Metabolic activation of nitrofurantoin: possible implications for carcinogenesis. Biochem. Pharmacol. 1979; 28: 601
   PubMed Web of Science ®Google Scholar
• Wang C. Y., Behrens B. C., Ichikawa M., Bryan G. T. Nitroreduction of 5-nitrofuran derivatives by rat liver xanthine oxidase and reduced nicotinamide adenine dinucleotide phosphate — cytochrome creductase. Biochem. Pharmacol. 1974; 23: 3395
   PubMed Web of Science ®Google Scholar
• Buege J. A., Aust S. D. Comparative studies of rat liver and lung NADPH-cytochromec reductase. Biochim. Biophys. Acta 1975; 385: 371
   PubMedGoogle Scholar
• Battelli M. G., Corte E. D., Stirpe G. Xanthine oxidase type D (dehydrogenase) in the intestine and other organs of the rat. Biochem. J. 1972; 126: 747
   PubMed Web of Science ®Google Scholar
• Mason R. P., Peterson F. J., Calaghan J. T., Hotzman J. L. Ascorbic acid destruction of the -O2 generated by nitrofurantoin and paraquat free radicals. Pharmacologist 1977; 19: 192
   Google Scholar
• Sasame H. A., Boyd M. R. Superoxide and hydrogen peroxide production and NADPH oxidation stimulated by nitrofurantoin in lung microsomes: possible implications for toxicity. Life Sci. 1979; 24: 1091
   PubMed Web of Science ®Google Scholar
• Misra H. P., Fridovich I. The role of superoxide anion in the autooxidation of epinephrine and a simple assay for superoxide dismutase. J. Biol. Chem. 1972; 247: 3170
   PubMed Web of Science ®Google Scholar
• Aufrére M. B., Hoener B. A., Vore M. Reductive metabolism of nitrofurantoin in the rat. Drug Metab. Dispoc. 1978; 6: 403
   PubMed Web of Science ®Google Scholar
• Etherton J. E., Gresham G. A. Early bronchiolar damage following paraquat poisoning in mice. J. Pathol. 1979; 128: 21
   PubMed Web of Science ®Google Scholar
• Reznik-Schüller H., Lijinsky W. in vivo autoradiography and nitrosoheptamethyleine carcin-ogenesis in hamsters. Cancer Res. 1979; 39: 72
   PubMedGoogle Scholar
• Grasso P., Williams M., Hodgson R., Wright M. G., Gangoli S. D. The histochemical distribution of aniline hydroxylase. Histochem. J. 1971; 3: 117
   PubMedGoogle Scholar
• Harris C. C., Frank A. L., Van Haaften C, Kaufman D. G., Connor R., Jackson F., Barrett L. A., McDowell E. M., Trump B. F. Binding of3H-benzo(a)pyrene to DNA in cultured human bronchus. Cancer Res. 1976; 36: 1011
   PubMed Web of Science ®Google Scholar
• Yang S. K., Gelboin H. V., Trump B. F., Autrup H. and Harris, C. C, Metabolic activation of benzo(a)pyrene and binding to DNA in cultured human bronchus. Cancer Res. 1977; 37: 1210
   PubMed Web of Science ®Google Scholar
• Evans M. J., Johnson L. V., Stephens R. J., Freeman G. Renewal of the terminal bronchiolar epithelium in the rat following exposure to NO2 or O3. Lab. Invest. 1976; 35: 246
   PubMed Web of Science ®Google Scholar
• Evans M. J., Cabral-Anderson L. J., Freeman G. Role of the Clara cell in renewal of the bronchiolar epithelium. Lab. Invest. 1978; 38: 648
   PubMed Web of Science ®Google Scholar
• Lum H., Schwartz L. W., Dungworth D. L., Tyler W. S. A comparative study of cell renewal after exposure to ozone or oxygen. Response of terminal bronchiolar epithelium in the rat. Am. Rev. Respir. Dis. 1978; 118: 335
   PubMed Web of Science ®Google Scholar
• Tischler A. S. Small cell carcinoma of the lung: cellular origin and relationship to other neoplasms. Semin. Oncol. 1978; 5: 244
   PubMed Web of Science ®Google Scholar
• Wattenberg L. W., Leong J. L. Histochemical demonstration of reduced pyridine nucleotide dependent polycyclic hydrocarbon metabolizing systems. J. Histochem. Cytochem. 1962; 10: 412
   Web of Science ®Google Scholar
• Campiche M. A., Gautier A., Hernandez E. I., Reymond A. An electron microscopy study of the fetal development of human lung. Pediatrics 1963; 32: 976
   PubMed Web of Science ®Google Scholar
• Hage E. The morphological development of the pulmonary epithelium of human foetuses studied by light and electron microscopy. Z. Anat. Entwicklungsgesch 1973; 140: 271
   PubMedGoogle Scholar
• O'Hare K. H., Sheridan M. N. Electron microscopic observations on the morphogenesis of the albino rat lung with special reference to pulmonary epithelial cells. Am. J. Anat. 1970; 127: 181
   PubMedGoogle Scholar
• Huang T. W., Carlson J. R., Bray T. M., Bradley B. J. 3-Methylindole-induced pulmonary injury in goats. Am. J. Pathol. 1977; 87: 647
   PubMed Web of Science ®Google Scholar
• Adamson I. Y. R., Bowden D. H., Cote M. G., Witschi H. Lung injury induced by butylated hydroxytoluene-cytodynamic and biochemical studies in mice. Lab. Invest. 1977; 36: 26
   PubMed Web of Science ®Google Scholar
• Hirai K., Witschi H., Côté M. Electron microscopy of butylated hydroxytoluene-induced lung damage in mice. Exp. Mol. Pathol. 1977; 27: 295
   PubMed Web of Science ®Google Scholar
• Shaw Y. S., Chen C. Ring hydroxylation of di-t-butylhydroxytoluene by rat liver microsomal preparations. Biochem. J. 1972; 128: 1285
   PubMed Web of Science ®Google Scholar
• Nakagawa Y., Hiraga K., Suga T. Biological fate of butylated hydroxytoluene (BHT); bindingin vitro to liver microsomes. Chem. Pharm. Bull. 1979; 27: 480
   PubMed Web of Science ®Google Scholar
• Kehrer J., Witschi H. The role of metabolism in the pulmonary toxicity of butylated hydroxytoluene (BHT). Fed. Proc. 1979; 38: 582
   Google Scholar
• Nakagawa Y., Hiraga K., Suga T. Biological fate of butylated hydroxytoluene (BHT); bindingin vivo of BHT to macromolecules of rat liver. Chem. Pharm. Bull. 1979; 27: 442
   PubMed Web of Science ®Google Scholar
• Williamson D., Esterez P., Witschi H. Studies on the pathogenesis of butylated hydroxytoluene-induced lung damage in mice. Toxicol. Appl. Pharmacol. 1978; 43: 577
   PubMed Web of Science ®Google Scholar
• Hook G. E. R., Bend J. R., Fouts J. R. Mixed-function oxidases and the alveolar macro-phage. Biochem. Pharmacol. 1972; 21: 3267
   PubMed Web of Science ®Google Scholar
• Harris C. C., Hsu I. C., Stoner G. D., Trump B. F., Selkirk J. K. Human pulmonary alveolar macrophages metabolise benzo(a)pyrene to proximate and ultimate mutagens. Nature (Lon-don) 1978; 272: 633
   PubMed Web of Science ®Google Scholar
• Witschi H. Proliferation of type II alveolar cells: a review of common responses in toxic lung injury. Toxicology 1976; 5: 267
   PubMed Web of Science ®Google Scholar
• Sebe Y. Perilla ketone. J. Chem. Soc. Jpn. 1943; 64: 1130
   Google Scholar
• Brettner A., Heitman E. R., Woodin W. G. Pulmonary complications of drug therapy. Ra-diology 1970; 96: 31
   Google Scholar
• Rosenow E. C. The spectrum of drug-induced pulmonary disease. Ann. Int. Med. 1972; 77: 977
   PubMed Web of Science ®Google Scholar
• Whitcomb M. E. Drug-induced lung disease. Chest 1973; 63: 418
   PubMed Web of Science ®Google Scholar
• Cole P. Drug-induced lung disease. Drugs 1977; 13: 422
   PubMed Web of Science ®Google Scholar
• Lippman M. Pulmonary reactions to drugs. Med. Clin. North Am. 1977; 61: 1353
   PubMed Web of Science ®Google Scholar
• Shanies H. M. Noncardiogenic pulmonary edema. Med. Clin. North Am. 1977; 61: 1319
   PubMed Web of Science ®Google Scholar
• Sostman H. D., Matthay R. A., Putman C. E. Cytotoxic drug-induced lung disease. Am. J. Med. 1977; 62: 608
   PubMed Web of Science ®Google Scholar
• Gould V. E., Miller J. Sclerosing alveolitis induced by cyclophosphamide. Am. J. Pathol. 1975; 81: 513
   PubMed Web of Science ®Google Scholar
• Olive P. L. Macromolecular, antineoplastic and radiosensitization effects of nitrofurans. Nitro-furans: Chemistry, Metabolism and Carcinogenesis, G. T. Bryan. Raven Press, New York 1978, chap. 5
   Google Scholar
• Goodman J., Hochstein P. Generation of free radicals and lipid peroxidation by redox cycling of adriamycin and daunomycin. Biochem. Biophys. Res. Commun. 1977; 77: 797
   PubMed Web of Science ®Google Scholar